EA038458B1 - Стабильная водная нанодисперсия водонерастворимых биоактивных соединений и способ ее получения - Google Patents

Стабильная водная нанодисперсия водонерастворимых биоактивных соединений и способ ее получения Download PDF

Info

Publication number
EA038458B1
EA038458B1 EA201692044A EA201692044A EA038458B1 EA 038458 B1 EA038458 B1 EA 038458B1 EA 201692044 A EA201692044 A EA 201692044A EA 201692044 A EA201692044 A EA 201692044A EA 038458 B1 EA038458 B1 EA 038458B1
Authority
EA
Eurasian Patent Office
Prior art keywords
nanodispersion
stabilizer
aqueous
predetermined amount
vol
Prior art date
Application number
EA201692044A
Other languages
English (en)
Russian (ru)
Other versions
EA201692044A1 (ru
Inventor
Рамбхау Деврадж
Пранати Чхатои
Нага Хемантх Кумар Парватхабхатла
Ананд Васант Дешмукх
Кришна Каушик Чинтабхатла
Original Assignee
Палс Фармасьютикалс Пвт. Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Палс Фармасьютикалс Пвт. Лтд. filed Critical Палс Фармасьютикалс Пвт. Лтд.
Publication of EA201692044A1 publication Critical patent/EA201692044A1/ru
Publication of EA038458B1 publication Critical patent/EA038458B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • Biochemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Colloid Chemistry (AREA)
EA201692044A 2014-04-09 2015-04-08 Стабильная водная нанодисперсия водонерастворимых биоактивных соединений и способ ее получения EA038458B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1872CH2014 IN2014CH01872A (cg-RX-API-DMAC7.html) 2014-04-09 2015-04-08
PCT/IB2015/052541 WO2015155703A2 (en) 2014-04-09 2015-04-08 Composition and method of producing nanoformulation of water insoluble bioactives in aqueous base

Publications (2)

Publication Number Publication Date
EA201692044A1 EA201692044A1 (ru) 2017-04-28
EA038458B1 true EA038458B1 (ru) 2021-08-31

Family

ID=54288490

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201692044A EA038458B1 (ru) 2014-04-09 2015-04-08 Стабильная водная нанодисперсия водонерастворимых биоактивных соединений и способ ее получения

Country Status (7)

Country Link
US (1) US11458096B2 (cg-RX-API-DMAC7.html)
EP (1) EP3129002A4 (cg-RX-API-DMAC7.html)
AU (1) AU2015246030B2 (cg-RX-API-DMAC7.html)
EA (1) EA038458B1 (cg-RX-API-DMAC7.html)
IN (1) IN2014CH01872A (cg-RX-API-DMAC7.html)
MX (1) MX2016013201A (cg-RX-API-DMAC7.html)
WO (1) WO2015155703A2 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106470548B (zh) 2014-04-30 2020-06-30 玛托克控股有限公司 抗微生物组合物
GB201716986D0 (en) 2017-10-16 2017-11-29 Matoke Holdings Ltd Antimicrobial compositions
FR3075661A1 (fr) * 2017-12-21 2019-06-28 Coatex Emulsion submicronique
EP3731801B1 (en) * 2017-12-29 2022-03-09 L'oreal Compositions for altering the color of hair
WO2019175830A1 (en) * 2018-03-14 2019-09-19 Azista Industries Pvt Ltd Cholecalciferol nanoemulsion formulations and methods for producing same
WO2023118928A1 (en) 2021-12-21 2023-06-29 Opella Healthcare Group Sas Stable nanoformulation for lipophilic actives, oral dosage form and process for its preparation

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5444041A (en) * 1991-04-19 1995-08-22 Ibah, Inc. Convertible microemulsion formulations
WO2011075623A1 (en) * 2009-12-18 2011-06-23 Latitude Pharmaceuticals, Inc. One - phase gel compos ition compri s ing phos pholi pids

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2091152C (en) 1993-03-05 2005-05-03 Kirsten Westesen Solid lipid particles, particles of bioactive agents and methods for the manfuacture and use thereof
US5518738A (en) 1995-02-09 1996-05-21 Nanosystem L.L.C. Nanoparticulate nsaid compositions
WO1997010814A1 (en) * 1995-09-18 1997-03-27 Vesifact Ag Propofol nanodispersions
DE19642359A1 (de) 1996-10-14 1998-04-16 Basf Ag Stabile Emulsionen und Trockenpulver von Mischungen fettlöslicher Vitamine, deren Herstellung und Verwendung
US5994414A (en) 1997-04-28 1999-11-30 Avon Products, Inc. Water-thin emulsion formed by high pressure homogenization process
DK1249230T3 (da) * 2001-04-12 2004-03-15 Vesifact Ag Mikroemulsion-prækoncentrater og mikroemulsioner indeholdende coenzym Q10
US6780324B2 (en) * 2002-03-18 2004-08-24 Labopharm, Inc. Preparation of sterile stabilized nanodispersions
CN1655762B (zh) 2002-06-17 2010-05-26 塔罗制药美国公司 布洛芬混悬剂
US8628690B2 (en) 2004-02-23 2014-01-14 The Texas A&M University System Nanoemulsion compositions and methods of use thereof
EP1597973A1 (en) 2004-05-18 2005-11-23 Nestec S.A. Oil-in-water emulsion for delivery
US20060051462A1 (en) * 2004-09-03 2006-03-09 Wang Jimmy X Self emulsifying compositions for delivering lipophilic coenzyme Q10 and other dietary ingredients
WO2008045107A2 (en) 2005-12-01 2008-04-17 University Of Massachusetts Lowell Botulinum nanoemulsions
CN101011355B (zh) * 2006-02-01 2013-01-02 陈献 经维生素e琥珀酸酯稳定的医药组合物、其制备及用途
WO2007103294A2 (en) 2006-03-07 2007-09-13 Novavax, Inc. Nanoemulsions of poorly soluble pharmaceutical active ingredients and methods of making the same
EP1938801A1 (en) 2006-12-22 2008-07-02 Biofrontera Bioscience GmbH Nanoemulsion
WO2009070642A1 (en) * 2007-11-28 2009-06-04 Medimmune, Llc Protein formulation
WO2009067734A1 (en) 2007-11-28 2009-06-04 Commonwealth Scientific And Industrial Research Organisation Nanoemulsions
EP2201937A1 (en) 2008-12-23 2010-06-30 Teva Pharmaceutical Industries Ltd. Formulations comprising vitamin D or derivatives thereof
JP6176894B2 (ja) 2009-03-09 2017-08-09 プロノヴァ・バイオファーマ・ノルゲ・アーエス 脂肪酸油混合物及び界面活性剤を含む組成物、並びにその方法及び使用
ES2530049T3 (es) * 2009-05-18 2015-02-26 Sigmoid Pharma Limited Composición que comprende gotas de aceite
CN102802624A (zh) * 2009-06-19 2012-11-28 太阳医药高级研发有限公司 药物的纳米分散体以及它的制备方法
EP3366280A1 (en) * 2010-03-12 2018-08-29 Berg LLC Intravenous formulations of coenzyme q10 (coq10) and methods of use thereof
US20110229516A1 (en) * 2010-03-18 2011-09-22 The Clorox Company Adjuvant phase inversion concentrated nanoemulsion compositions
SE536746C2 (sv) 2010-05-12 2014-07-08 Stora Enso Oyj En komposition innehållande mikrofibrillerad cellulosa och en process för tillverkning av en komposition
US8835509B2 (en) 2010-05-31 2014-09-16 Arbro Pharmaceuticals Ltd. Self emulsifying drug delivery system for a curcuminoid based composition
JP2013537185A (ja) 2010-09-08 2013-09-30 プロノヴァ・バイオファーマ・ノルゲ・アーエス 遊離酸の形のｅｐａおよびｄｈａを含む脂肪酸油混合物と界面活性剤とスタチンとを含む組成物
WO2013008083A1 (en) 2011-07-13 2013-01-17 National Institute Of Pharmaceutical Education And Research (Niper) Pharmaceutical composition for enhancing anticancer efficacy of tamoxifen
NZ596015A (en) 2011-10-26 2014-04-30 Anzamed Internat Ltd Method and composition for the treatment of pain and/or inflammation
GB201204377D0 (en) 2012-03-13 2012-04-25 Givaudan Sa Composition

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5444041A (en) * 1991-04-19 1995-08-22 Ibah, Inc. Convertible microemulsion formulations
WO2011075623A1 (en) * 2009-12-18 2011-06-23 Latitude Pharmaceuticals, Inc. One - phase gel compos ition compri s ing phos pholi pids

Also Published As

Publication number Publication date
EP3129002A4 (en) 2017-11-08
EP3129002A2 (en) 2017-02-15
US11458096B2 (en) 2022-10-04
US20180177723A1 (en) 2018-06-28
IN2014CH01872A (cg-RX-API-DMAC7.html) 2015-05-08
WO2015155703A3 (en) 2015-12-30
WO2015155703A2 (en) 2015-10-15
EA201692044A1 (ru) 2017-04-28
MX2016013201A (es) 2017-04-25
AU2015246030A1 (en) 2016-11-24
AU2015246030B2 (en) 2020-03-12

Similar Documents

Publication Publication Date Title
EA038458B1 (ru) Стабильная водная нанодисперсия водонерастворимых биоактивных соединений и способ ее получения
US20220257510A1 (en) Compositions for Nanoemulsion Delivery Systems
EP3159012B1 (en) Nanoemulsions having reversible continuous and dispersed phases
JP5603852B2 (ja) 凍結乾燥ナノエマルション
Urimi et al. Formulation development and upscaling of lipid nanocapsules as a drug delivery system for a novel cyclic GMP analogue intended for retinal drug delivery
CN110545796A (zh) 用于活性化合物的局部递送系统
EP3104840B1 (en) Parenteral compositions of celecoxib
US20070298111A1 (en) Fine Particle-Containing Composition and Manufacturing Method Therefor
Al-Hussaniy et al. Nanoemulsions as medicinal components in insoluble medicines
US8617606B2 (en) Hydrogel suspension and manufacturing process thereof
CH650928A5 (fr) Emulsion huile-dans-l'eau pour suralimentation.
RS60119B1 (sr) Poboljšane formulacije levosimendana za intravensko davanje kao infuzija ili injekcija i infuzioni koncentrat
JP2009062288A (ja) ソホロリピッドを含む経皮吸収制御剤及びその製造方法
JP2007501253A (ja) マクロライド含有水中油エマルジョン
US20240009122A1 (en) Small Molecule Formulation
JP4449329B2 (ja) Ｗ／ｏ／ｗ型複合エマルション
Sarhan et al. Exploring the antidiabetic effect of various therapeutic essential oils synergistically with repaglinide
EP3124049A1 (en) Process for producing composition of emulsion preparation type
CN101322719A (zh) 一种三氧化二砷固体脂质纳米粒、其制剂及其制备方法
EP4169515B1 (en) Emulsion, injection agent, and emulsion preparation method
CN106714787A (zh) 含丙泊酚的水包油型乳液组合物及其制造方法
US20210069110A1 (en) Non-aqueous composition having drug carried therein, and method for producing same
Saeed Formulation and evaluation of flavonoid derivatives’ as topical nano-emulgel to treat the wound healing in diabetic patients
HK1233192B (en) Nanoemulsions having reversible continuous and dispersed phases
NIKAM et al. NANOEMULSION-BASED DRUG DELIVERY SYSTEMS